Co-Authors
This is a "connection" page, showing publications co-authored by Fabrice Barlesi and Frank Griscelli.
Connection Strength
0.644
-
Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
Score: 0.239
-
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
Score: 0.060
-
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021 12; 28(12):3297-3315.
Score: 0.060
-
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021 03 11; 12(3):258.
Score: 0.058
-
Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):947-956.
Score: 0.058
-
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients. Nat Commun. 2021 01 27; 12(1):634.
Score: 0.058
-
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell. 2020 09 17; 182(6):1401-1418.e18.
Score: 0.056
-
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol. 2020 07; 31(7):961-964.
Score: 0.055